N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo

Medicinal Chemistry

Volumn 3, Issue 3, 2007, Pages 269-276

  Anil Kumar, C ^a   Nanjunda Swamy, S ^a   Gaonkar, S L ^a   Basappa, ^a   Salimath, Bharathi P ^a   Rangappa, Kanchugarakoppal S ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Antitumor activity; EAT cells; HUVEC; Imidazole derivative

Indexed keywords

2 BUTYL 4 CHLORO 1 [2 (6,7,8,9 TETRAHYDRO 2 METHYL 4OXO 4H PYRIDO[1,2 A]PYRIMIDIN 3 YL)ETHYL] 1H IMIDAZOLE 5 CARBALDEHYDE; 2 BUTYL 4CHLORO 1 [2 (PYRROLIDIN 1 YL)ETHYL] 1H IMIDAZOLE 5 CARBALDEHYDE; 2 BUTYL 5 CHLORO 3 (2 MORPHOLIN 4 YLETHYL) 3H IMIDAZOLE 4 CARBALDEHYDE; 2 BUTYL 5 CHLORO 3 (2 PIPERAZIN 1 YLETHYL) 3H IMIDAZOLE 4 CARBALDEHYDE; 2 BUTYL 5 CHLORO 3 (2 PIPERIDIN 1 YL ETHYL) 3H IMIDAZOLE 4 CARBALDEHYDE; 2 BUTYL 5 CHLORO 3 [2 (2 METHYL 4 OXO 4H PYRIDO[1,2 A]PYRIMIDIN 3 YL)ETHYL] 3H IMIDAZOLE 4 CARBALDEHYDE; 2 BUTYL 5 CHLORO 3H IMIDAZOLE 4 CARBALDEHYDE DERIVATIVE; ANTINEOPLASTIC AGENT; IMIDAZOLE DERIVATIVE; N,N DIMETHYLFORMAMIDE; POTASSIUM CARBONATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASCITES FLUID; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLOGY; DRUG STRUCTURE; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MORBIDITY; MORTALITY; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PERITONEUM CANCER; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; UMBILICAL VEIN;

ALDEHYDES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMIDAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34248674920     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340607780620699     Document Type: Article

References (18)

1. Spasov, A.R.; Iezhitsa I.N.; Bugaeva, L.I.; Anisimova, V.A. Khim.-Farm. Zhurn., 1999, 33, 6.
2. Labanauskas, L.K.; Brukstus, A.B.; Gaidelis, P.G.; Buchinskaite, V.A.; Udrenaite, E.B.; Dauksas, V.K. Pharm. Chem. J., 2000, 34, 353.
3. Grassmann, S.; Sadek, B.; Ligneau, X.; Elz, S.; Ganellin, C.R.; Arrang, J.M.; Schwartz, J.C.; Stark, H.; Schunack, W. Eur. J. Pharm. Sci., 2002, 15, 367.
4. Can-Eke, B.; Puskullu, M.O.; Buyukbingol, E.; Iscan, M. Chem-Biol. Interactions., 1998, 113, 65.
5. Sevak, R.; Paul, A.; Goswami, S.; Santini, D. Pharmacol. Res., 2002, 46, 351.
6. (a) Williams, T.M. Exp. Opin. Ther. Patents., 1998, 8, 553.
7. (b) Shen, W.; Fakhourly, S.; Donner, G.; Henry, K.; Lee, J.; Zhang, H.; Cohen, J.; Warner, R.; Saeed, B.; Cherian S.; Tahir, S.; Kovar, P.; Bauch, J.; Ng, S.C.; Marsh, K.; Sham, H..; Rosenberg, S.; Biorg. Med. Chem. Lett., 1999, 9, 703.
8. Anthony, N.J.; Gomez, R.P.; Schaber, M.D.; Scott, D.M.; Hamilton, K.A.; O'Neil, T.J.; Koblan, K.J.;, Graham, S.L.; Hartman, G.D.; Daksha, S.; Rands, E.; Kohl, N.E.; Jackson, B.G.; Oliff, A.I. J. Med. Chem., 1999, 42, 3356.
9. Silverman, R.M. The Organic Chemistry of Drug Design and Drug Action, Academic Press: New York, 1992.
10. Martin, K.J.; Chin Shin, F.; Clark, G.M.; Degen, D.; Wayma, M.; Von Hoff, D.D.; Kaddurach-Dasuk, R. J. Natl. Cancer Inst., 1994, 86, 608.
11. Gunther, W.; Pawlak, E.; Damasceno, R.; Arnold H.; Terzis, A.J. Br. J. Cancer, 2003, 88, 463.
12. Carini, D.J.; Duncia, J.V.; Aldrich, P.E.; Chiu, A.T.; Johnson, A.L.; Pierce, M.E.; Price, W.A.; Santella, J.B.; Wells, G.J.; Wexler, R.R.; Wong, P.C.; Sung-Eun, Y.; Timmermans, P.B.M.W.M. J. Med. Chem., 1991, 34, 2525.
13. Beeranahally, D.H.; Basappa.; Madegowda, M.; Mantelingu, K.; Sridhar, A.M.; Javaregowda, P.S.; Rangappa, K.S. Anal. Sci., 2003, 31.
14. Basappa.; Satish Kumar, M.; Nanjunda Swamy, S.; Mahendra, M.; Shashidhara. Prasad, J.; Viswanath, B.S.; Rangappa, K.S. Bioorg. Med. Chem. Lett., 2004, 14(14), 3679.
15. Basappa.; Sadashiva, M.P.; Mantelingu, K.; Nanjunda Swamy, S.; Rangappa, K.S. Bioorg. Med. Chem., 2003, 11, 4539.
16. Prabbakar, B.T.; Khanum, S.A.; Jayashree, K.; Salimath, B.P.; Shashikanth, S. Bioorg. Med. Chem., 2006, 14(2), 435.
17. Srinivas, G.; Anto, R.J.; Srinivas, P.; Vidhyalakshmi, S.; Senan, V.P.; Karunagaran, D. Eur. J. Pharmacol., 2003, 473(2-3), 117.
18. Tanaka, M.T.; Suda, K.; Haze, N.; Nakamura, K.; Motoyoshi, M.; Mizuki, S.; Ohga, K.; Hatake, A.H.; Drummond, N.S. Nat. Med., 1996, 2, 317.